Emil M.

Emil M. has extensive experience in regulatory affairs and quality assurance, currently serving in a Regulatory Affairs - CMC role at Bristol Myers Squibb since April 2022. Previously, Emil held similar positions at Kite Pharma from October 2018 to April 2022, where responsibilities encompassed both regulatory affairs and quality. Prior to that, Emil worked in Quality Assurance/Regulatory Affairs at Teligent, Inc. from August 2016 to October 2018 and was involved in Analytical Development at Charles River Laboratories from September 2014 to August 2016. Emil M. holds a Master of Science in Regulatory Affairs and Quality Assurance from Temple University School of Pharmacy and a Bachelor of Arts in Neuroscience from The College of Wooster.